The United Nations Office on Drugs and Crime (UNODC) has released its World Drug Report 2026, warning of a rapid transformation in global drug markets. According to the report, organized crime groups are introducing more potent synthetic drugs, experimenting with new trafficking routes, and aggressively targeting emerging markets.

**Key Statistics:**

  • An estimated 331 million people used illicit drugs worldwide in 2024, up from 5.2 percent a decade earlier.
  • Cannabis remains the world's most widely used drug, with approximately 256 million users.
  • Synthetic opioids such as fentanyls and nitazenes are spreading rapidly due to a supply gap caused by Afghanistan's opium ban.

**Background:**

The report highlights the growing challenges for law enforcement and public health systems worldwide. UNODC Executive Director Monica Juma noted that an unprecedented surge in new drug types poses greater health risks than previous substances. The consequences of drug use extend far beyond addiction, contributing to millions of premature deaths, economic disruption, organized crime, insecurity, and violence.

**Regional Trends:**

  • Methamphetamine trafficking has become increasingly global, with new production hubs and trafficking routes expanding supplies into Africa, Europe, and the Middle East.
  • Cannabis markets have evolved significantly over the past decade, partly influenced by legalization and decriminalization policies adopted in several jurisdictions.
  • Global cocaine production continues to outpace previous records, driven by expanding cultivation and higher productivity.

**Call for Action:**

The UNODC urges governments to strengthen efforts against transnational criminal organizations by expanding intelligence-sharing, coordinating joint operations, and increasing investment in drug prevention and treatment programs. Addressing underlying social factors such as poverty, homelessness, mental health conditions, and limited access to healthcare remains essential to reducing both drug demand and the wider harms associated with illicit drug markets.